APO Research
Talk to an analyst

APO RESEARCH · REPORT

Parenteral Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Research

Parenteral Drugs Industry Research Report 2026

20 December 2025143 pages

Choose your research edition.

Industry ResearchParenteral Drugs Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Parenteral Drugs Industry Growth and Trends Forecast to 2032128 pages · $3,450 USDMarket StructureGlobal Parenteral Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Parenteral Drugs Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Parenteral Drugs Market Analysis and Forecast 2026-2032212 pages · $4,950 USD

Market perspective

The global Parenteral Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Parenteral Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Parenteral Drugs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Parenteral Drugs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Parenteral Drugs include Albert David, Aspen Holdings, AXA Parenterals Ltd, BAG Healthcare, Baxter Healthcare Corporation, Beximco Pharma, BML Parenteral Drugs, Cook Pharmica and Ostuka Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Parenteral Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Parenteral Drugs Market by Company

Albert David

Aspen Holdings

AXA Parenterals Ltd

BAG Healthcare

Baxter Healthcare Corporation

Beximco Pharma

BML Parenteral Drugs

Cook Pharmica

Ostuka Pharmaceutical

Ozon Pharmaceuticals Ltd

Patheon

PSI Ltd

Southwest Pharmaceutical

B. Braun

Cisen

Fresenius

Pfizer (Hospira)

Kelun Pharma

Acebright

SSY Group

Teva Pharmaceutical Industries

Abbott

Parenteral Drugs Segment by Type

LVP Drug

SVP Drug

Parenteral Drugs Segment by Application

Hospitals

Medical Centers

Others

Parenteral Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Parenteral Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Parenteral Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Parenteral Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Parenteral Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Parenteral Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Parenteral Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Parenteral Drugs Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Parenteral Drugs Sales (k units) of Manufacturers (2021-2026) Table 7. Global Parenteral Drugs Sales Market Share by Manufacturers (2021-2026) Table 8. Global Parenteral Drugs Revenue of Manufacturers (2021-2026) Table 9. Global Parenteral Drugs Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Parenteral Drugs Average Price (US$/unit) of Manufacturers (2021-2026) Table 11. Global Parenteral Drugs Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Parenteral Drugs, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Parenteral Drugs, Product Type & Application Table 14. Global Parenteral Drugs Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Parenteral Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Albert David Company Information Table 19. Albert David Business Overview Table 20. Albert David Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 21. Albert David Parenteral Drugs Product Portfolio Table 22. Albert David Recent Developments Table 23. Aspen Holdings Company Information Table 24. Aspen Holdings Business Overview Table 25. Aspen Holdings Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 26. Aspen Holdings Parenteral Drugs Product Portfolio Table 27. Aspen Holdings Recent Developments Table 28. AXA Parenterals Ltd Company Information Table 29. AXA Parenterals Ltd Business Overview Table 30. AXA Parenterals Ltd Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 31. AXA Parenterals Ltd Parenteral Drugs Product Portfolio Table 32. AXA Parenterals Ltd Recent Developments Table 33. BAG Healthcare Company Information Table 34. BAG Healthcare Business Overview Table 35. BAG Healthcare Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 36. BAG Healthcare Parenteral Drugs Product Portfolio Table 37. BAG Healthcare Recent Developments Table 38. Baxter Healthcare Corporation Company Information Table 39. Baxter Healthcare Corporation Business Overview Table 40. Baxter Healthcare Corporation Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 41. Baxter Healthcare Corporation Parenteral Drugs Product Portfolio Table 42. Baxter Healthcare Corporation Recent Developments Table 43. Beximco Pharma Company Information Table 44. Beximco Pharma Business Overview Table 45. Beximco Pharma Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Beximco Pharma Parenteral Drugs Product Portfolio Table 47. Beximco Pharma Recent Developments Table 48. BML Parenteral Drugs Company Information Table 49. BML Parenteral Drugs Business Overview Table 50. BML Parenteral Drugs Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 51. BML Parenteral Drugs Parenteral Drugs Product Portfolio Table 52. BML Parenteral Drugs Recent Developments Table 53. Cook Pharmica Company Information Table 54. Cook Pharmica Business Overview Table 55. Cook Pharmica Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 56. Cook Pharmica Parenteral Drugs Product Portfolio Table 57. Cook Pharmica Recent Developments Table 58. Ostuka Pharmaceutical Company Information Table 59. Ostuka Pharmaceutical Business Overview Table 60. Ostuka Pharmaceutical Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. Ostuka Pharmaceutical Parenteral Drugs Product Portfolio Table 62. Ostuka Pharmaceutical Recent Developments Table 63. Ozon Pharmaceuticals Ltd Company Information Table 64. Ozon Pharmaceuticals Ltd Business Overview Table 65. Ozon Pharmaceuticals Ltd Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Ozon Pharmaceuticals Ltd Parenteral Drugs Product Portfolio Table 67. Ozon Pharmaceuticals Ltd Recent Developments Table 68. Patheon Company Information Table 69. Patheon Business Overview Table 70. Patheon Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Patheon Parenteral Drugs Product Portfolio Table 72. Patheon Recent Developments Table 73. PSI Ltd Company Information Table 74. PSI Ltd Business Overview Table 75. PSI Ltd Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. PSI Ltd Parenteral Drugs Product Portfolio Table 77. PSI Ltd Recent Developments Table 78. Southwest Pharmaceutical Company Information Table 79. Southwest Pharmaceutical Business Overview Table 80. Southwest Pharmaceutical Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Southwest Pharmaceutical Parenteral Drugs Product Portfolio Table 82. Southwest Pharmaceutical Recent Developments Table 83. B. Braun Company Information Table 84. B. Braun Business Overview Table 85. B. Braun Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. B. Braun Parenteral Drugs Product Portfolio Table 87. B. Braun Recent Developments Table 88. Cisen Company Information Table 89. Cisen Business Overview Table 90. Cisen Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Cisen Parenteral Drugs Product Portfolio Table 92. Cisen Recent Developments Table 93. Fresenius Company Information Table 94. Fresenius Business Overview Table 95. Fresenius Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Fresenius Parenteral Drugs Product Portfolio Table 97. Fresenius Recent Developments Table 98. Pfizer (Hospira) Company Information Table 99. Pfizer (Hospira) Business Overview Table 100. Pfizer (Hospira) Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Pfizer (Hospira) Parenteral Drugs Product Portfolio Table 102. Pfizer (Hospira) Recent Developments Table 103. Kelun Pharma Company Information Table 104. Kelun Pharma Business Overview Table 105. Kelun Pharma Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. Kelun Pharma Parenteral Drugs Product Portfolio Table 107. Kelun Pharma Recent Developments Table 108. Acebright Company Information Table 109. Acebright Business Overview Table 110. Acebright Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 111. Acebright Parenteral Drugs Product Portfolio Table 112. Acebright Recent Developments Table 113. SSY Group Company Information Table 114. SSY Group Business Overview Table 115. SSY Group Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 116. SSY Group Parenteral Drugs Product Portfolio Table 117. SSY Group Recent Developments Table 118. Teva Pharmaceutical Industries Company Information Table 119. Teva Pharmaceutical Industries Business Overview Table 120. Teva Pharmaceutical Industries Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 121. Teva Pharmaceutical Industries Parenteral Drugs Product Portfolio Table 122. Teva Pharmaceutical Industries Recent Developments Table 123. Abbott Company Information Table 124. Abbott Business Overview Table 125. Abbott Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 126. Abbott Parenteral Drugs Product Portfolio Table 127. Abbott Recent Developments Table 128. Global Parenteral Drugs Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 129. Global Parenteral Drugs Sales by Region (2021-2026) & (k units) Table 130. Global Parenteral Drugs Sales Market Share by Region (2021-2026) Table 131. Global Parenteral Drugs Sales by Region (2027-2032) & (k units) Table 132. Global Parenteral Drugs Sales Market Share by Region (2027-2032) Table 133. Global Parenteral Drugs Revenue by Region (2021-2026) & (US$ Million) Table 134. Global Parenteral Drugs Revenue Market Share by Region (2021-2026) Table 135. Global Parenteral Drugs Revenue by Region (2027-2032) & (US$ Million) Table 136. Global Parenteral Drugs Revenue Market Share by Region (2027-2032) Table 137. North America Parenteral Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. North America Parenteral Drugs Sales by Country (2021-2026) & (k units) Table 139. North America Parenteral Drugs Sales by Country (2027-2032) & (k units) Table 140. North America Parenteral Drugs Revenue by Country (2021-2026) & (US$ Million) Table 141. North America Parenteral Drugs Revenue by Country (2027-2032) & (US$ Million) Table 142. Europe Parenteral Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 143. Europe Parenteral Drugs Sales by Country (2021-2026) & (k units) Table 144. Europe Parenteral Drugs Sales by Country (2027-2032) & (k units) Table 145. Europe Parenteral Drugs Revenue by Country (2021-2026) & (US$ Million) Table 146. Europe Parenteral Drugs Revenue by Country (2027-2032) & (US$ Million) Table 147. Asia Pacific Parenteral Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 148. Asia Pacific Parenteral Drugs Sales by Country (2021-2026) & (k units) Table 149. Asia Pacific Parenteral Drugs Sales by Country (2027-2032) & (k units) Table 150. Asia Pacific Parenteral Drugs Revenue by Country (2021-2026) & (US$ Million) Table 151. Asia Pacific Parenteral Drugs Revenue by Country (2027-2032) & (US$ Million) Table 152. South America Parenteral Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 153. South America Parenteral Drugs Sales by Country (2021-2026) & (k units) Table 154. South America Parenteral Drugs Sales by Country (2027-2032) & (k units) Table 155. South America Parenteral Drugs Revenue by Country (2021-2026) & (US$ Million) Table 156. South America Parenteral Drugs Revenue by Country (2027-2032) & (US$ Million) Table 157. Middle East and Africa Parenteral Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 158. Middle East and Africa Parenteral Drugs Sales by Country (2021-2026) & (k units) Table 159. Middle East and Africa Parenteral Drugs Sales by Country (2027-2032) & (k units) Table 160. Middle East and Africa Parenteral Drugs Revenue by Country (2021-2026) & (US$ Million) Table 161. Middle East and Africa Parenteral Drugs Revenue by Country (2027-2032) & (US$ Million) Table 162. Global Parenteral Drugs Sales by Type (2021-2026) & (k units) Table 163. Global Parenteral Drugs Sales by Type (2027-2032) & (k units) Table 164. Global Parenteral Drugs Sales Market Share by Type (2021-2026) Table 165. Global Parenteral Drugs Sales Market Share by Type (2027-2032) Table 166. Global Parenteral Drugs Revenue by Type (2021-2026) & (US$ Million) Table 167. Global Parenteral Drugs Revenue by Type (2027-2032) & (US$ Million) Table 168. Global Parenteral Drugs Revenue Market Share by Type (2021-2026) Table 169. Global Parenteral Drugs Revenue Market Share by Type (2027-2032) Table 170. Global Parenteral Drugs Price by Type (2021-2026) & (US$/unit) Table 171. Global Parenteral Drugs Price by Type (2027-2032) & (US$/unit) Table 172. Global Parenteral Drugs Sales by Application (2021-2026) & (k units) Table 173. Global Parenteral Drugs Sales by Application (2027-2032) & (k units) Table 174. Global Parenteral Drugs Sales Market Share by Application (2021-2026) Table 175. Global Parenteral Drugs Sales Market Share by Application (2027-2032) Table 176. Global Parenteral Drugs Revenue by Application (2021-2026) & (US$ Million) Table 177. Global Parenteral Drugs Revenue by Application (2027-2032) & (US$ Million) Table 178. Global Parenteral Drugs Revenue Market Share by Application (2021-2026) Table 179. Global Parenteral Drugs Revenue Market Share by Application (2027-2032) Table 180. Global Parenteral Drugs Price by Application (2021-2026) & (US$/unit) Table 181. Global Parenteral Drugs Price by Application (2027-2032) & (US$/unit) Table 182. Key Raw Materials Table 183. Raw Materials Key Suppliers Table 184. Parenteral Drugs Distributors List Table 185. Parenteral Drugs Customers List Table 186. Parenteral Drugs Industry Trends Table 187. Parenteral Drugs Industry Drivers Table 188. Parenteral Drugs Industry Restraints Table 189. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Parenteral Drugs Product Image Figure 5. Global Parenteral Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Parenteral Drugs Market Size (2021-2032) & (US$ Million) Figure 7. Global Parenteral Drugs Sales (2021-2032) & (k units) Figure 8. Global Parenteral Drugs Average Price (US$/unit) & (2021-2032) Figure 9. LVP Drug Product Image Figure 10. SVP Drug Product Image Figure 11. Hospitals Product Image Figure 12. Medical Centers Product Image Figure 13. Others Product Image Figure 14. Global Parenteral Drugs Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Parenteral Drugs, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Parenteral Drugs Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Parenteral Drugs Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Parenteral Drugs Sales by Region in 2025 Figure 20. Global Parenteral Drugs Revenue by Region in 2025 Figure 21. North America Parenteral Drugs Market Size by Country in 2025 Figure 22. North America Parenteral Drugs Sales Market Share by Country (2021-2032) Figure 23. North America Parenteral Drugs Revenue Market Share by Country (2021-2032) Figure 24. United States Parenteral Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Parenteral Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Mexico Parenteral Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Parenteral Drugs Market Size by Country in 2025 Figure 28. Europe Parenteral Drugs Sales Market Share by Country (2021-2032) Figure 29. Europe Parenteral Drugs Revenue Market Share by Country (2021-2032) Figure 30. Germany Parenteral Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Parenteral Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Parenteral Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Parenteral Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Russia Parenteral Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Spain Parenteral Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands Parenteral Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Switzerland Parenteral Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Sweden Parenteral Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Poland Parenteral Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific Parenteral Drugs Market Size by Country in 2025 Figure 41. Asia Pacific Parenteral Drugs Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific Parenteral Drugs Revenue Market Share by Country (2021-2032) Figure 43. China Parenteral Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan Parenteral Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea Parenteral Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India Parenteral Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia Parenteral Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Taiwan Parenteral Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Parenteral Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Parenteral Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America Parenteral Drugs Market Size by Country in 2025 Figure 52. South America Parenteral Drugs Sales Market Share by Country (2021-2032) Figure 53. South America Parenteral Drugs Revenue Market Share by Country (2021-2032) Figure 54. Brazil Parenteral Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Parenteral Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Chile Parenteral Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Colombia Parenteral Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Middle East and Africa Parenteral Drugs Market Size by Country in 2025 Figure 59. Middle East and Africa Parenteral Drugs Sales Market Share by Country (2021-2032) Figure 60. Middle East and Africa Parenteral Drugs Revenue Market Share by Country (2021-2032) Figure 61. Egypt Parenteral Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. South Africa Parenteral Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Israel Parenteral Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Türkiye Parenteral Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. GCC Countries Parenteral Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Global Parenteral Drugs Sales Market Share by Type (2021-2032) Figure 67. Global Parenteral Drugs Revenue Market Share by Type (2021-2032) Figure 68. Global Parenteral Drugs Price (US$/unit) by Type (2021-2032) Figure 69. Global Parenteral Drugs Sales Market Share by Application (2021-2032) Figure 70. Global Parenteral Drugs Revenue Market Share by Application (2021-2032) Figure 71. Global Parenteral Drugs Price (US$/unit) by Application (2021-2032) Figure 72. Parenteral Drugs Value Chain Figure 73. Parenteral Drugs Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Parenteral Drugs Industry Opportunities and Challenges

Scope & coverage.

Types
  • LVP Drug
  • SVP Drug
Applications
  • Hospitals
  • Medical Centers
  • Others
Companies covered
  • Albert David
  • Aspen Holdings
  • AXA Parenterals Ltd
  • BAG Healthcare
  • Baxter Healthcare Corporation
  • Beximco Pharma
  • BML Parenteral Drugs
  • Cook Pharmica
  • Ostuka Pharmaceutical
  • Ozon Pharmaceuticals Ltd
  • Patheon
  • PSI Ltd
  • Southwest Pharmaceutical
  • B. Braun
  • Cisen
  • Fresenius
  • Pfizer (Hospira)
  • Kelun Pharma
  • Acebright
  • SSY Group
  • Teva Pharmaceutical Industries
  • Abbott

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Parenteral Drugs Market Size (2021-2032)
  4. 2.2.2 Global Parenteral Drugs Sales (2021-2032)
  5. 2.2.3 Global Parenteral Drugs Market Average Price (2021-2032)
  6. 2.3 Parenteral Drugs by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 LVP Drug
  9. 2.3.3 SVP Drug
  10. 2.4 Parenteral Drugs by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Hospitals
  13. 2.4.3 Medical Centers
  14. 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Parenteral Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Parenteral Drugs Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Parenteral Drugs Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Parenteral Drugs Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Parenteral Drugs Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Parenteral Drugs, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Parenteral Drugs, Product Type & Application
  8. 3.8 Global Manufacturers of Parenteral Drugs, Established Date
  9. 3.9 Global Parenteral Drugs Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Albert David
  2. 4.1.1 Albert David Company Information
  3. 4.1.2 Albert David Business Overview
  4. 4.1.3 Albert David Parenteral Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Albert David Parenteral Drugs Product Portfolio
  6. 4.1.5 Albert David Recent Developments
  7. 4.2 Aspen Holdings
  8. 4.2.1 Aspen Holdings Company Information
  9. 4.2.2 Aspen Holdings Business Overview
  10. 4.2.3 Aspen Holdings Parenteral Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Aspen Holdings Parenteral Drugs Product Portfolio
  12. 4.2.5 Aspen Holdings Recent Developments
  13. 4.3 AXA Parenterals Ltd
  14. 4.3.1 AXA Parenterals Ltd Company Information
  15. 4.3.2 AXA Parenterals Ltd Business Overview
  16. 4.3.3 AXA Parenterals Ltd Parenteral Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 AXA Parenterals Ltd Parenteral Drugs Product Portfolio
  18. 4.3.5 AXA Parenterals Ltd Recent Developments
  19. 4.4 BAG Healthcare
  20. 4.4.1 BAG Healthcare Company Information
  21. 4.4.2 BAG Healthcare Business Overview
  22. 4.4.3 BAG Healthcare Parenteral Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 BAG Healthcare Parenteral Drugs Product Portfolio
  24. 4.4.5 BAG Healthcare Recent Developments
  25. 4.5 Baxter Healthcare Corporation
  26. 4.5.1 Baxter Healthcare Corporation Company Information
  27. 4.5.2 Baxter Healthcare Corporation Business Overview
  28. 4.5.3 Baxter Healthcare Corporation Parenteral Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Baxter Healthcare Corporation Parenteral Drugs Product Portfolio
  30. 4.5.5 Baxter Healthcare Corporation Recent Developments
  31. 4.6 Beximco Pharma
  32. 4.6.1 Beximco Pharma Company Information
  33. 4.6.2 Beximco Pharma Business Overview
  34. 4.6.3 Beximco Pharma Parenteral Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Beximco Pharma Parenteral Drugs Product Portfolio
  36. 4.6.5 Beximco Pharma Recent Developments
  37. 4.7 BML Parenteral Drugs
  38. 4.7.1 BML Parenteral Drugs Company Information
  39. 4.7.2 BML Parenteral Drugs Business Overview
  40. 4.7.3 BML Parenteral Drugs Parenteral Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 BML Parenteral Drugs Parenteral Drugs Product Portfolio
  42. 4.7.5 BML Parenteral Drugs Recent Developments
  43. 4.8 Cook Pharmica
  44. 4.8.1 Cook Pharmica Company Information
  45. 4.8.2 Cook Pharmica Business Overview
  46. 4.8.3 Cook Pharmica Parenteral Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Cook Pharmica Parenteral Drugs Product Portfolio
  48. 4.8.5 Cook Pharmica Recent Developments
  49. 4.9 Ostuka Pharmaceutical
  50. 4.9.1 Ostuka Pharmaceutical Company Information
  51. 4.9.2 Ostuka Pharmaceutical Business Overview
  52. 4.9.3 Ostuka Pharmaceutical Parenteral Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Ostuka Pharmaceutical Parenteral Drugs Product Portfolio
  54. 4.9.5 Ostuka Pharmaceutical Recent Developments
  55. 4.10 Ozon Pharmaceuticals Ltd
  56. 4.10.1 Ozon Pharmaceuticals Ltd Company Information
  57. 4.10.2 Ozon Pharmaceuticals Ltd Business Overview
  58. 4.10.3 Ozon Pharmaceuticals Ltd Parenteral Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Ozon Pharmaceuticals Ltd Parenteral Drugs Product Portfolio
  60. 4.10.5 Ozon Pharmaceuticals Ltd Recent Developments
  61. 4.11 Patheon
  62. 4.11.1 Patheon Company Information
  63. 4.11.2 Patheon Business Overview
  64. 4.11.3 Patheon Parenteral Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Patheon Parenteral Drugs Product Portfolio
  66. 4.11.5 Patheon Recent Developments
  67. 4.12 PSI Ltd
  68. 4.12.1 PSI Ltd Company Information
  69. 4.12.2 PSI Ltd Business Overview
  70. 4.12.3 PSI Ltd Parenteral Drugs Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 PSI Ltd Parenteral Drugs Product Portfolio
  72. 4.12.5 PSI Ltd Recent Developments
  73. 4.13 Southwest Pharmaceutical
  74. 4.13.1 Southwest Pharmaceutical Company Information
  75. 4.13.2 Southwest Pharmaceutical Business Overview
  76. 4.13.3 Southwest Pharmaceutical Parenteral Drugs Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Southwest Pharmaceutical Parenteral Drugs Product Portfolio
  78. 4.13.5 Southwest Pharmaceutical Recent Developments
  79. 4.14 B. Braun
  80. 4.14.1 B. Braun Company Information
  81. 4.14.2 B. Braun Business Overview
  82. 4.14.3 B. Braun Parenteral Drugs Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 B. Braun Parenteral Drugs Product Portfolio
  84. 4.14.5 B. Braun Recent Developments
  85. 4.15 Cisen
  86. 4.15.1 Cisen Company Information
  87. 4.15.2 Cisen Business Overview
  88. 4.15.3 Cisen Parenteral Drugs Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Cisen Parenteral Drugs Product Portfolio
  90. 4.15.5 Cisen Recent Developments
  91. 4.16 Fresenius
  92. 4.16.1 Fresenius Company Information
  93. 4.16.2 Fresenius Business Overview
  94. 4.16.3 Fresenius Parenteral Drugs Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Fresenius Parenteral Drugs Product Portfolio
  96. 4.16.5 Fresenius Recent Developments
  97. 4.17 Pfizer (Hospira)
  98. 4.17.1 Pfizer (Hospira) Company Information
  99. 4.17.2 Pfizer (Hospira) Business Overview
  100. 4.17.3 Pfizer (Hospira) Parenteral Drugs Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Pfizer (Hospira) Parenteral Drugs Product Portfolio
  102. 4.17.5 Pfizer (Hospira) Recent Developments
  103. 4.18 Kelun Pharma
  104. 4.18.1 Kelun Pharma Company Information
  105. 4.18.2 Kelun Pharma Business Overview
  106. 4.18.3 Kelun Pharma Parenteral Drugs Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Kelun Pharma Parenteral Drugs Product Portfolio
  108. 4.18.5 Kelun Pharma Recent Developments
  109. 4.19 Acebright
  110. 4.19.1 Acebright Company Information
  111. 4.19.2 Acebright Business Overview
  112. 4.19.3 Acebright Parenteral Drugs Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Acebright Parenteral Drugs Product Portfolio
  114. 4.19.5 Acebright Recent Developments
  115. 4.20 SSY Group
  116. 4.20.1 SSY Group Company Information
  117. 4.20.2 SSY Group Business Overview
  118. 4.20.3 SSY Group Parenteral Drugs Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 SSY Group Parenteral Drugs Product Portfolio
  120. 4.20.5 SSY Group Recent Developments
  121. 4.21 Teva Pharmaceutical Industries
  122. 4.21.1 Teva Pharmaceutical Industries Company Information
  123. 4.21.2 Teva Pharmaceutical Industries Business Overview
  124. 4.21.3 Teva Pharmaceutical Industries Parenteral Drugs Sales, Revenue and Gross Margin (2021-2026)
  125. 4.21.4 Teva Pharmaceutical Industries Parenteral Drugs Product Portfolio
  126. 4.21.5 Teva Pharmaceutical Industries Recent Developments
  127. 4.22 Abbott
  128. 4.22.1 Abbott Company Information
  129. 4.22.2 Abbott Business Overview
  130. 4.22.3 Abbott Parenteral Drugs Sales, Revenue and Gross Margin (2021-2026)
  131. 4.22.4 Abbott Parenteral Drugs Product Portfolio
  132. 4.22.5 Abbott Recent Developments
5 Global Parenteral Drugs Market Scenario by Region
  1. 5.1 Global Parenteral Drugs Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Parenteral Drugs Sales by Region: 2021-2032
  3. 5.2.1 Global Parenteral Drugs Sales by Region: 2021-2026
  4. 5.2.2 Global Parenteral Drugs Sales by Region: 2027-2032
  5. 5.3 Global Parenteral Drugs Revenue by Region: 2021-2032
  6. 5.3.1 Global Parenteral Drugs Revenue by Region: 2021-2026
  7. 5.3.2 Global Parenteral Drugs Revenue by Region: 2027-2032
  8. 5.4 North America Parenteral Drugs Market Facts & Figures by Country
  9. 5.4.1 North America Parenteral Drugs Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Parenteral Drugs Sales by Country (2021-2032)
  11. 5.4.3 North America Parenteral Drugs Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Parenteral Drugs Market Facts & Figures by Country
  16. 5.5.1 Europe Parenteral Drugs Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Parenteral Drugs Sales by Country (2021-2032)
  18. 5.5.3 Europe Parenteral Drugs Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Parenteral Drugs Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Parenteral Drugs Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Parenteral Drugs Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Parenteral Drugs Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Parenteral Drugs Market Facts & Figures by Country
  41. 5.7.1 South America Parenteral Drugs Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Parenteral Drugs Sales by Country (2021-2032)
  43. 5.7.3 South America Parenteral Drugs Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.7.7 Colombia
  48. 5.8 Middle East and Africa Parenteral Drugs Market Facts & Figures by Country
  49. 5.8.1 Middle East and Africa Parenteral Drugs Market Size by Country: 2021 VS 2025 VS 2032
  50. 5.8.2 Middle East and Africa Parenteral Drugs Sales by Country (2021-2032)
  51. 5.8.3 Middle East and Africa Parenteral Drugs Revenue by Country (2021-2032)
  52. 5.8.4 Egypt
  53. 5.8.5 South Africa
  54. 5.8.6 Israel
  55. 5.8.7 Türkiye
  56. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Parenteral Drugs Sales by Type (2021-2032)
  2. 6.1.1 Global Parenteral Drugs Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Parenteral Drugs Sales Market Share by Type (2021-2032)
  4. 6.2 Global Parenteral Drugs Revenue by Type (2021-2032)
  5. 6.2.1 Global Parenteral Drugs Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Parenteral Drugs Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Parenteral Drugs Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Parenteral Drugs Sales by Application (2021-2032)
  2. 7.1.1 Global Parenteral Drugs Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Parenteral Drugs Sales Market Share by Application (2021-2032)
  4. 7.2 Global Parenteral Drugs Revenue by Application (2021-2032)
  5. 7.2.1 Global Parenteral Drugs Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Parenteral Drugs Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Parenteral Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Parenteral Drugs Value Chain Analysis
  2. 8.1.1 Parenteral Drugs Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Parenteral Drugs Production Mode & Process
  5. 8.2 Parenteral Drugs Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Parenteral Drugs Distributors
  8. 8.2.3 Parenteral Drugs Customers
9 Global Parenteral Drugs Analyzing Market Dynamics
  1. 9.1 Parenteral Drugs Industry Trends
  2. 9.2 Parenteral Drugs Industry Drivers
  3. 9.3 Parenteral Drugs Industry Opportunities and Challenges
  4. 9.4 Parenteral Drugs Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst